secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2022-10-11T23:59:59+00:00
Accession:  0001193125-22-260149
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orthofix and SeaSpine combine in all-stock merger of equals; 0.4163 exchange ratio, ~$693M pro forma revenue
--------------------------------------------------------------------------------

- SeaSpine shareholders to receive 0.4163 Orthofix shares per SPNE share; combined ownership 56.5% Orthofix, 43.5% SeaSpine.
- Pro forma revenue ~$693M (trailing twelve months ended Sep 30, 2022); combined company has ~1,600 employees in 68 countries.
- Jon Serbousek (Orthofix CEO) to be Executive Chairman; Keith Valentine (SeaSpine CEO) to be President and CEO.
- Transaction expected to be adjusted EBITDA accretive by second year post-close; requires stockholder and antitrust approvals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000119312522260149/0001193125-22-260149-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000119312522260149/d345457d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-260149

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer